BRIEF published on 09/02/2026 at 12:35, 11 days 1 hour ago Immunic to Host Virtual R&D Day on Multiple Sclerosis Biotechnology Immunic Vidofludimus Calcium Relapsing MS R&D Event
PRESS RELEASE published on 09/02/2026 at 12:30, 11 days 1 hour ago Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026 Immunic, Inc. to host a virtual R&D day on relapsing multiple sclerosis on September 9, 2026, discussing its Phase 3 trial asset, vidofludimus calcium, to address neurologic diseases Immunic Inc. Phase 3 Trial Vidofludimus Calcium Relapsing Multiple Sclerosis Virtual R&D Day
BRIEF published on 09/01/2026 at 12:35, 12 days 1 hour ago Immunic Appoints Chitrang Davé as Chief Data and Digital Officer Multiple Sclerosis Immunic Vidofludimus Calcium Chitrang Davé Data And Digital
PRESS RELEASE published on 09/01/2026 at 12:30, 12 days 1 hour ago Immunic Appoints Chitrang Davé as Chief Data and Digital Officer Immunic appoints Chitrang Davé as Chief Data and Digital Officer, reinforcing commitment to building a robust data ecosystem for potential NDA submission and commercialization Chief Data Officer Immunic Digital Officer NDA Submission Chitrang Davé
BRIEF published on 08/11/2026 at 12:35, 1 month 2 days ago Immunic, Inc. Reports Q2 2026 Financial Results and Updates Vidofludimus Calcium Leadership Appointments Multiple Sclerosis Trials Biotech Investments Immunic Financials
PRESS RELEASE published on 08/11/2026 at 12:30, 1 month 2 days ago Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update Immunic, Inc. reports Q2 2026 financial results and corporate update, with leadership team expansions and Phase 3 trials progress for vidofludimus calcium in MS Financial Results Corporate Update Immunic Inc. Vidofludimus Calcium Q2 2026
BRIEF published on 08/10/2026 at 22:10, 1 month 2 days ago Elena Ridloff Joins Immunic's Board as Strategic Director Vidofludimus Calcium Immunic Board Elena Ridloff Biotechnology Leadership Phase 3 ENSURE
PRESS RELEASE published on 08/10/2026 at 22:05, 1 month 2 days ago Immunic Appoints Elena Ridloff to Board of Directors Immunic appoints Elena Ridloff, a financial and capital markets expert, to its Board of Directors, enhancing leadership as the company approaches pivotal phase 3 ENSURE Readout for Multiple Sclerosis treatments Board Of Directors Immunic Elena Ridloff MS Treatments ENSURE Readout
BRIEF published on 07/09/2026 at 12:35, 2 months 4 days ago Immunic Announces Participation in July Investor Conferences Biotechnology Investor Conferences Immunic Inc. Oral Therapies Neurologic Diseases
PRESS RELEASE published on 07/09/2026 at 12:30, 2 months 4 days ago Immunic to Participate in Investor Conferences in July Immunic, Inc. (Nasdaq: IMUX) to participate in investor conferences in July, presenting at Leerink Partners Therapeutics Forum and B. Riley Securities Mind, Muscle & Vision Summit in Boston Investor Conferences Immunic Inc B. Riley Securities Neurologic Diseases Leerink Partners
Published on 09/12/2026 at 02:35, 1 day 11 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 14 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 16 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 20 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 19 hours 46 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 6 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 15 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 15 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 17 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 2 days 18 hours ago Availability of the 2026 Interim Financial Report
